AI and Innovation – The Pathology Network

ABOUT US
Our Story

Our Story
The Pathology Network embodies the desire for all African patients to access efficient and affordable specialized laboratory diagnostic testing.
It is an online laboratory diagnostic platform developed by African pathologists who, using process engineering, have improved access, increased the speed and reduced the cost of diagnosis for tens of thousands of patients across East Africa.

Our Team

Our Team
We are proud of our stellar and diverse team comprising professionals in customer service, logistics, laboratory quality management, software engineering, data science, finance, human resource management, sales, communications and governance. The teamwork truly makes the dream work.

Impact

Impact
Pathology and laboratory medicine form the scientific basis for the practice of modern medicine. They enable patients to trust their diagnosis, allow clinicians to confidently prescribe treatment and provide the healthcare system with the information needed to operate efficiently and predictably. Our novel workflow has tangible impact on individual patients as well as the entire healthcare system.

Partners

Partners
We are proud to partner with laboratories across East Africa which offer specialised tests such as histology, immunohistochemistry, and genomic testing. Our partner pathologists are standardising diagnoses and are located in multiple countries including Kenya, the UK, Spain and Australia. We also partner with universities, logistics companies, charities and others to make quality diagnosis available to patients in Africa and beyond.

Investors

Investors
Our company is owned and supported by a diverse group of investors from across the world. Our investors share our social mission of enabling equal access to diagnosis for all.
PRODUCTS & SERVICES
Supported Tests

Supported Tests

Our products and services

Spes360

Spes360

SPES360
TALK TO US

AI and the Future of TPN

April 16, 2025February 27, 2025 by TPN Admin

Bridging Africa’s Diagnostic Gap with AI

Our Story

Our Team

Impact

Partners

Investors

Spes360

SPES360